<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00637208</url>
  </required_header>
  <id_info>
    <org_study_id>RVS-002-IL</org_study_id>
    <secondary_id>MHMC grant</secondary_id>
    <nct_id>NCT00637208</nct_id>
  </id_info>
  <brief_title>Sclerotherapy of Internal Spermatic Veins in Patients With Varicocele and Localized Prostate Cancer</brief_title>
  <official_title>Selective Retrograde Venography and Sclerotherapy of Internal Spermatic Veins and Associated Venous Bypasses and Retro-Peritoneal Collateral in Patients With Bilateral Varicocele and Localized Prostate Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maaynei Hayesha Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maaynei Hayesha Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with varicocele in whon early prostate cancer will be found will undergo venographic
      embolization of both spermatic veins. The study hypothesis is that this procedure will induce
      a gradual regression of the prostate volume that may decrease prostate cancer cells. Close
      follow-up will ensure that necessary therapy will be provided if needed according to clinical
      criteria. Results in terms of prostate size PSA level and tumor size will be recorded.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety performance of the procedure. The change in tumor size and prostate cancer cells as evaluated by trans-rectal ultrasound and prostate biopsy</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The change in size of the prostate as evaluated by ultrasound Change in PSA value. Reduction of above 20% in nocturia</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Watch-full follow-up</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>venographic occlusion of spermatic veins</intervention_name>
    <description>Through the femoral vein a catheter is inserted into the spermatic veins in succession and the veins are occluded.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males age 45-75

          -  Prostate cancer

          -  Presence of varicocele

          -  No contraindication for venography

        Exclusion Criteria:

          -  Diseases or medications which prevent interventional vascular procedures
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Maaynei Hayesha Medical Center</name>
      <address>
        <city>Bnei Brak</city>
        <zip>51544</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2008</study_first_submitted>
  <study_first_submitted_qc>March 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2008</study_first_posted>
  <last_update_submitted>March 14, 2008</last_update_submitted>
  <last_update_submitted_qc>March 14, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 17, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr Uriel Levinger</name_title>
    <organization>Maaynei Hayesha Medical Center</organization>
  </responsible_party>
  <keyword>prostate cancer</keyword>
  <keyword>venography</keyword>
  <keyword>male patients</keyword>
  <keyword>Localized microscopic prostate cancer up to Gleason 6 (3+3)</keyword>
  <keyword>PSA level &lt;14</keyword>
  <keyword>presence of varicocele</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
    <mesh_term>Varicocele</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

